Morocco, Kenya, Singapore, Australia, Germany, France, Canada, and Saudi Arabia
Description
Rucaparib Tablets 200mg, 250mg and 300mg are oral targeted anticancer medicines belonging to the PARP inhibitor class. Rucaparib may be prescribed for selected patients with certain ovarian, fallopian tube, primary peritoneal and BRCA-mutated prostate cancers.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter providing oncology and specialty medicines to authorized international buyers.
Rucaparib Tablets Uses
Rucaparib may be prescribed under specialist supervision for:
Certain ovarian cancers
Fallopian tube cancer
Primary peritoneal cancer
BRCA-mutated metastatic castration-resistant prostate cancer
Rucaparib inhibits PARP enzymes involved in DNA repair, which can increase DNA damage in susceptible cancer cells.
Rucaparib 200mg, 250mg & 300mg Benefits
Targeted PARP inhibitor treatment
Oral tablet formulation
Used for selected BRCA-associated cancers
Multiple strengths available
Suitable for physician-directed dose adjustments
Rucaparib Dosage
Rucaparib dosage depends on the cancer indication, previous treatment, biomarker status, kidney and liver function, and individual treatment tolerance.
For certain approved adult indications, a commonly recommended regimen is 600mg twice daily, with or without food. The 200mg, 250mg and 300mg tablets may be used for physician-directed dose modifications.
Patients should take Rucaparib only as prescribed and should not change the dose without medical advice.
Rucaparib Side Effects
Common side effects may include:
Nausea and vomiting
Diarrhea or constipation
Abdominal discomfort
Fatigue and weakness
Loss of appetite
Taste changes
Mouth sores
Rucaparib can also cause serious blood-related adverse effects and rare MDS/AML. Regular medical monitoring is important.
Affordable Rucaparib Tablets Supply
Cordium Pharmaceuticals Pvt Ltd provides competitive pharmaceutical sourcing and international export support for Rucaparib Tablets 200mg, 250mg and 300mg.
We receive pharmaceutical supply inquiries from:
Morocco | Kenya | Singapore | Australia | Germany | France | Canada | Saudi Arabia
Our services can support authorized:
Pharmaceutical distributors
Hospitals
Pharmacies
Licensed importers
Healthcare procurement organizations
Pricing and availability may vary according to order quantity, destination, documentation, shipping requirements and local regulations.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
Oncology and specialty medicine portfolio
Competitive international pricing
Global export support
Export documentation assistance
Support for authorized pharmaceutical buyers
Professional pharmaceutical sourcing
Frequently Asked Questions
What are Rucaparib Tablets used for?
Rucaparib is a targeted anticancer medicine used for selected cancer indications, including certain ovarian and BRCA-mutated prostate cancers.
What strengths of Rucaparib are available?
Rucaparib tablets are available in 200mg, 250mg and 300mg strengths.
Is Rucaparib a chemotherapy medicine?
Rucaparib is an oral targeted anticancer medicine classified as a PARP inhibitor.
Can Rucaparib be purchased without a prescription?
Rucaparib is a prescription anticancer medicine and should be used under qualified medical supervision.
Does Cordium Pharmaceuticals supply Rucaparib internationally?
Cordium Pharmaceuticals provides international pharmaceutical export support for authorized buyers, subject to destination-country regulations.
Conclusion
Rucaparib Tablets 200mg, 250mg & 300mg are targeted PARP inhibitor medicines used for selected cancer patients. Appropriate medical evaluation, biomarker testing, individualized dosing and regular monitoring are essential.
Cordium Pharmaceuticals Pvt Ltd provides affordable and reliable pharmaceutical sourcing support from India for authorized buyers in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, subject to applicable regulations.
